Seeber S - Search Results

1

Cytotoxicity of adriamycin, idarubicin, and vincristine in acute myeloid leukemia: chemosensitization by verapamil in relation to P-glycoprotein expression.

Müller MR, Lennartz K, Boogen C, Nowrousian MR, Rajewsky MF, Seeber S. Müller MR, et al. Among authors: seeber s. Ann Hematol. 1992 Nov;65(5):206-12. doi: 10.1007/BF01703946. Ann Hematol. 1992. PMID: 1360820

2

Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.

Müller MR, Lennartz K, Nowrousian MR, Dux R, Tsuruo T, Rajewsky MF, Seeber S. Müller MR, et al. Among authors: seeber s. Cytometry. 1994 Jan 1;15(1):64-72. doi: 10.1002/cyto.990150111. Cytometry. 1994. PMID: 7512893 Free article.

3

Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry.

Müller MR, Lennartz K, Baack B, Heim MM, Seeber S, Scheulen ME. Müller MR, et al. Among authors: seeber s. Int J Clin Pharmacol Ther. 2000 Apr;38(4):180-6. doi: 10.5414/cpp38180. Int J Clin Pharmacol Ther. 2000. PMID: 10783827

4

Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome.

Müller MR, Seiler F, Thomale J, Buschfort C, Rajewsky MF, Seeber S. Müller MR, et al. Among authors: seeber s. Cancer Res. 1994 Aug 15;54(16):4524-31. Cancer Res. 1994. PMID: 8044803

5

Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.

Schütt P, Ebeling P, Buttkereit U, Brandhorst D, Opalka B, Poser M, Müller S, Flasshove M, Moritz T, Seeber S, Nowrousian MR. Schütt P, et al. Among authors: seeber s. Ann Hematol. 2005 Sep;84(9):594-600. doi: 10.1007/s00277-005-1007-7. Epub 2005 Mar 3. Ann Hematol. 2005. PMID: 15744524 Clinical Trial.

6

Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas.

Nowrousian MR, Anders CH, Niederle N, Nagel-Hiemke M, Moritz T, Seeber S, Schmidt CG. Nowrousian MR, et al. Among authors: seeber s. Ann Oncol. 1991 Jan;2 Suppl 1:25-30. doi: 10.1093/annonc/2.suppl_1.25. Ann Oncol. 1991. PMID: 1710486 Free article.

7

Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo.

Schröder J, Esteban M, Müller MR, Kasimir-Bauer S, Bamberger U, Heckel A, Seeber S, Scheulen ME. Schröder J, et al. Among authors: seeber s. J Cancer Res Clin Oncol. 1996;122(5):307-12. doi: 10.1007/BF01261408. J Cancer Res Clin Oncol. 1996. PMID: 8609155

8

Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myeloma.

Fosså A, Muer M, Kasper C, Welt A, Seeber S, Nowrousian MR. Fosså A, et al. Among authors: seeber s. Leukemia. 1998 Mar;12(3):422-6. doi: 10.1038/sj.leu.2400945. Leukemia. 1998. PMID: 9529138 Clinical Trial.

9

DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemia.

Müller MR, Buschfort C, Thomale J, Lensing C, Rajewsky MF, Seeber S. Müller MR, et al. Among authors: seeber s. Clin Cancer Res. 1997 Nov;3(11):2055-61. Clin Cancer Res. 1997. PMID: 9815597

10

Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma.

Fosså A, Brandhorst D, Myklebust JH, Seeber S, Nowrousian MR. Fosså A, et al. Among authors: seeber s. Exp Hematol. 1999 Nov;27(11):1621-6. doi: 10.1016/s0301-472x(99)00105-8. Exp Hematol. 1999. PMID: 10560909 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters